Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis [Phase 2]
Phase 2a open-label trial evaluating GR-MD-02 for safety and efficacy in psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Immunologic Response to Secukinumab in Plaque Psoriasis [Phase 4]
Phase 4 trial update evaluating immunologic response to secukinumab in patients with psoriasis shows completed results.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial results for IDP-122 topical lotion in moderate-to-severe plaque psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial assessing safety and efficacy of IDP-118 lotion for plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) [Phase 4]
Phase 4 clinical trial update for a Danish population-based assessment addressing psoriasis and psoriatic arthritis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Granulocytapheresis in Psoriasis [NA]
A clinical trial update indicates termination for granulocytapheresis in psoriasis, with results posted in 2020.
-
FDA approval · 2020-08-07FDA Approved: ACITRETIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Acitretin from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis [Phase 1, Phase 2]
A clinical trial update on ESR-114 topical treatment for psoriatic plaque, completed phases 1 and 2 assessing safety, pharmacokinetics, and …
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris [Phase 1]
Phase 1 clinical trial update for ixekizumab in Chinese participants with psoriasis vulgaris has been completed with results posted.
-
FDA approval · 2020-07-17FDA Approved: VECTICAL — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for VECTICAL (calcitriol) from Galderma Laboratories to expand its labeling for use in psoriasis…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial comparing methotrexate to secukinumab safety in psoriasis patients with metabolic syndrome; status is unknown.
-
FDA approval · 2020-07-14FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Viona Pharmaceuticals Inc)
FDA approved the original application for Betamethasone Dipropionate by Viona Pharmaceuticals Inc, granting it as a generic topical corticos…
-
FDA approval · 2020-07-07FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The U.S. FDA approved a supplemental application for betamethasone dipropionate from Glenmark Pharmaceuticals Inc., USA. This action adds re…
-
FDA approval · 2020-06-25FDA Approved: ACITRETIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for ACITRETIN from Mylan Pharmaceuticals Inc., resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis [Phase 1]
Phase 1 trial evaluating safety, tolerability, and efficacy of topical PF-06763809 in mild to moderate chronic plaque psoriasis; completed w…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis [NA]
Clinical trial update on excimer laser phototherapy for psoriasis; study is terminated with results posted.
-
FDA approval · 2020-06-17FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original application for Betamethasone Dipropionate topical, a potent corticosteroid for inflammatory …
-
FDA approval · 2020-06-15FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., indicating an approval related to the gene…
-
FDA approval · 2020-06-09FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Betamethasone Dipropionate by Actavis Pharma, Inc., indicating an update to the product's approv…
-
FDA approval · 2020-06-01FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's Triamcinolone acetonide via an Original Application (ANDA) for a generic formulation.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis [Phase 3]
Phase 3 trial update for guselkumab (CNTO 1959) in moderate to severe plaque psoriasis; results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. [Phase 2]
Phase 2 randomized trial evaluating a dipeptidyl peptidase-4 inhibitor in patients with psoriasis and type 2 diabetes; results posted after …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Taltz in Combination With Enstilar for Psoriasis [Phase 4]
Phase 4 trial update investigating Taltz in combination with Enstilar for psoriasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Duobrii in Combination With Biologics [Phase 4]
Phase 4 clinical trial update evaluating Duobrii in combination with biologics for psoriasis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis [Phase 2]
Phase 2 open-label pilot study assessing CC1004 in severe plaque psoriasis, focusing on pharmacodynamics, pharmacokinetics, safety, and prel…